ArticleCommunications biology2024

Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages.

Melanie R Walker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.